| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 05/29/2008 | US20080125425 Pyrrolo[3,2-D] pyrimidines that are selective antagonists of A2badenosine receptors |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125410 7-chloro-N,N-9-trimethyl-2-(6-methylpyridin-3-yl)-9H-pyrimido[4,5-b]indole-4-carboxamide; ethyl 7-chloro-9-methyl-2-phenyl-9H-pyrimido[4,5-b]indole-4-carboxylate; 4-[(4-azetidin-1-yl)piperidin-1-ylcarbonyl]-7-chloro-9-methyl-2-phenyl-9H-pyrimido-[4,5-b]indole; Alzheimer's or Parkinson's disease |
| 05/29/2008 | US20080125399 N-[3-(trifluoromethyl)pyridin-2-yl]-4-methyl-6-methyl-3-oxo-4-aza-5 alpha -androst-5-en-17 beta -acetamide; useful for the treatment of conditions caused by androgen deficiency such as osteoporosis, osteopenia, glucocorticoid-induced osteoporosis, periodontal disease, cancer cachexia, Alzheimer's disease |
| 05/29/2008 | US20080124807 Protein tagging reagents |
| 05/29/2008 | US20080124455 c6-c50 armoatic rings fused with pyrrole ring, substituted with diaminioaryliene rings; good solubility and high thermal stability; improved turn-on voltage, efficiency, color purity and luminance; wet spinning ( spin coating, spray or inkjet printing) and heat transfer |
| 05/29/2008 | US20080121873 Organic Thin Film Transistor Material, Organic Thin Film Transistor, Field-Effect Transistor, Switching Element, Organic Semiconductor Material and Organic Semiconductor Film |
| 05/29/2008 | DE102006055716A1 Imidazo(1,5-b)pyridazin-amido-Liganden und deren Komplexverbindungen Imidazo (1,5-b) pyridazine-amido ligands and their complexes |
| 05/29/2008 | DE102006054757A1 Neue aza-bicyclische Verbindungen und ihre Verwendung New aza-bicyclic compounds and their use |
| 05/29/2008 | CA2670083A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2670044A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | CA2670042A1 Heterobicyclic matrix metalloprotease inhibitors |
| 05/29/2008 | CA2670031A1 Heterobicyclic metalloprotease inhibitors |
| 05/29/2008 | CA2669991A1 Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| 05/29/2008 | CA2669888A1 Novel aza-bicyclic compounds and their use as stimulators of soluble guanylate cyclase |
| 05/29/2008 | CA2669839A1 2-hydroxy-1,3-diaminopropane derivatives |
| 05/29/2008 | CA2650227A1 Substituted pyrazolopyrimidines |
| 05/28/2008 | EP1925614A1 Anxiolytic agents with reduced sedative and ataxic effects |
| 05/28/2008 | EP1924585A1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative |
| 05/28/2008 | EP1924584A1 Use of fused imidazole derivatives to mediate ccr3 related conditions |
| 05/28/2008 | EP1924562A2 Pyrazolone derivatives |
| 05/28/2008 | EP1863817B1 Substituted, bicyclic 8-pyrrolidino-benzimidazoles, method for their production and their use as medicaments |
| 05/28/2008 | EP1828194B1 Tetracyclic imidazo-benzodiazepines as gaba receptors modulators |
| 05/28/2008 | EP1537115B1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 05/28/2008 | CN101189239A Protein kinase inhibitors |
| 05/28/2008 | CN101189238A Piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN101189235A 2-pyrrolidone derivatives and their uses for the treatment of inflammatory conditions and pain |
| 05/28/2008 | CN101189233A Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 05/28/2008 | CN101189225A Heteroaryl substituted pyrazinyl-piperazine-piperidines with CXCR3 antagonist activity |
| 05/28/2008 | CN100390176C Method for extracting chlorophyl from silkworm faeces by microwave pretreatment and preparing chlorophyllin copper and sodium salts |
| 05/28/2008 | CN100390175C Process for extracting and puritying haem |
| 05/27/2008 | US7378521 Preparation of 2-(2-arylmorpholin-2-yl) ethanol derivatives and intermediates |
| 05/27/2008 | US7378520 to silicon wafer; condensation of a carbon-substituted dipyrrolemethane with a dipyrromethane-1,9-dicarbinol then oxidation; substituents provide ability for high temperature attachment to silicon at two linkages |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378426 Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3 |
| 05/27/2008 | US7378424 Derivatives of pyrimido[6, 1-A]isoquinolin-4-one |
| 05/27/2008 | US7378423 Antiproliferative, anticancer, antitumor agents; rheumatism; N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-acetamide; a p15, and/or a protein inducing action, and/or an MEK inhibitory action; side effect reduction |
| 05/27/2008 | US7378418 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 05/27/2008 | US7378417 Pyrazolo-pyrimidine derivatives |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/27/2008 | US7378237 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/22/2008 | WO2008060301A1 7-substituted purine derivatives for immunosuppression |
| 05/22/2008 | WO2008060248A1 Indole sustituted pyrimidines and use thereof in the treatment of cancer |
| 05/22/2008 | WO2008059373A1 Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists |
| 05/22/2008 | WO2008059238A1 Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008037881A3 Derivatives of pyrrolizine, indolizine and quinolizine, preparation thereof and therapeutic use thereof |
| 05/22/2008 | WO2008022024A3 Imidazole amines as inhibitors of beta-secretase |
| 05/22/2008 | WO2007130824A3 Fused heterocylic compounds and their use as mglur5 modulators |
| 05/22/2008 | US20080119523 3-[(2-{[4-(hexyloxycarbonylaminoiminomethyl) phenylamino]methyl}-1-methyl-1h-benzimidazol-5- carbonyl)pyridin-2-ylamino]propionic acid ethylester methansulfonate and its use as a medicament |
| 05/22/2008 | US20080119497 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones |
| 05/22/2008 | US20080119493 5,6-Dialkyl-7-Aminotriazolopyrimidines, their Preparation and their Use for Controlling Harmful Fungi, and Compositions Comprising these Compounds |
| 05/22/2008 | US20080119469 Novel Compounds |
| 05/22/2008 | US20080119467 Purine Derivatives, Compositions Containing Them and Use Thereof |
| 05/22/2008 | CA2669686A1 7-substituted purine derivatives for immunosuppression |
| 05/22/2008 | CA2669357A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/21/2008 | EP1922321A1 Pyrazoloý1,5-a¨pyrimidine compounds and pharmaceutical compositions containing them |
| 05/21/2008 | EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 05/21/2008 | EP1922135A1 Hindered cyclic polyamines and their salts for acid gas scrubbing process |
| 05/21/2008 | EP1599206A4 Aminocyclopentyl fused heterotricylicamide modulators of chemokine receptor activity |
| 05/21/2008 | EP1444228B1 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors |
| 05/21/2008 | CN101184759A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
| 05/21/2008 | CN101182321A Indolizine heterocyclic nitrogen naphthoquinone derivatives as well as preparation method and anticancer use thereof |
| 05/21/2008 | CN100389115C Pyridyloxymethyl and benzisoxazole azabicyclic derivatives |
| 05/20/2008 | USRE40332 Fungicidal trifluoromethylalkylamino-triazolopyrimidines |
| 05/20/2008 | US7375216 Preparation of metal mesoporphyrin compounds |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375110 Nicotinic cholinergic receptors modulators; pain, neurodegenerative diseases; neurotransmission dysfuctions; central and autonomic nervous systems disorders; 1'-(3-pyridyl)-spiro[1-azabicyclo[2.2.1]heptane-2,3'-pyrrolidine] |
| 05/20/2008 | US7375102 inflammatory diseases, immune disorders, multiple sclerosis, rheumatoid arthritis, psoriasis; CXCR3 chemokine receptor modulators; 2-(4-fluoro-3-trifluoromethyl-phenyl)-N-(2-methanesulfonyl-ethyl)-N-(1-{4-oxo-3-[4-(2,2,2-trifluoro-ethoxy)-phenyl]-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl}-ethyl)-acetamide |
| 05/20/2008 | US7375099 Malonamide derivatives |
| 05/20/2008 | US7375093 Nuclear receptor-based inducible gene expression system |
| 05/20/2008 | US7374857 Such as 5,5'-bis[2-nonafluorobutanesulfonyloxy-1H-isoindole-1,3(2H)-dione]; efficiency, solubility, stability, photosensitivity |
| 05/20/2008 | CA2453123C Intermediate for condensed benzazepine derivatives |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2359008C Triazolo-pyridazine derivatives as ligands for gaba receptors |
| 05/15/2008 | WO2008058126A2 Imidazo[1,2-b]pyridazine and pyrazolo[1,5-a]pyrimidine derivatives and their use as protein kinase inhibitors |
| 05/15/2008 | WO2008058064A1 Amine-linked multicyclic compounds as inhibitors of the proline transporter |
| 05/15/2008 | WO2008057995A2 Hcv protease inhibitors |
| 05/15/2008 | WO2008057994A2 Pyrrolotriazine kinase inhibitors |
| 05/15/2008 | WO2008057938A1 Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 05/15/2008 | WO2008057875A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057873A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057871A2 Inhibitors of hepatitis c virus |
| 05/15/2008 | WO2008057512A2 Imidazopyrazines as protein kinase inhibitors |
| 05/15/2008 | WO2008057252A2 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and use therewith |
| 05/15/2008 | WO2008056746A1 Compound for organic electroluminescent device and organic electroluminescent device |
| 05/15/2008 | WO2008056433A1 Dendritic polyamidoamine phthalocyanine derivative |
| 05/15/2008 | WO2008056187A1 Imidazolopyrimidines and imidazolotriazine derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 05/15/2008 | WO2008056150A1 Heterocyclyc sulfonamides having edg-i antagonistic activity |
| 05/15/2008 | WO2008055959A1 Novel compounds useful for the treatment of degenerative & inflammatory diseases |
| 05/15/2008 | WO2008055934A1 Amorphous form of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo [1,5-a]pyrimidin-7-yl]-phenyl-n-methyl-acetamide |
| 05/15/2008 | WO2008039420A3 Novel inhibitors of beta-lactamase |
| 05/15/2008 | WO2008037681A8 5-{2-[4-(2-methyl-5-quinolinyl)-l-piperidinyl] ethyl} quinolinone derivatives as 5ht1a receptor modulators for treating sexual dysfunction, cognition impairement, psychotic disorders, anxiety, depression, etc. |
| 05/15/2008 | WO2008033798A3 A pyrrolopyrazin as syk-kinase inhibitor |
| 05/15/2008 | WO2008021385A3 Processes for preparing intermediates of pemetrexed |